Loop S M, Nishiyama K, Hellström I, Woodbury R G, Brown J P, Hellström K E
Int J Cancer. 1981 Jun 15;27(6):775-81. doi: 10.1002/ijc.2910270608.
BALB/c mice were immunized with human melanoma cells and their spleen cells hybridized with NS-1 myeloma cells. The hybrids were screened for the production of antibodies that bound to melanoma cells. Two hybridomas of interesting specificity were identified and cloned. Hybridoma 5.1 produce an IgG1 antibody that binds to about half of the melanomas and carcinomas tested. The target is a polypeptide with an apparent molecular weight of 210 kilodaltons on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The antigen, denoted p210, is also expressed in normal adult brain and in certain fetal tissues. Hybridoma 6.1 produces an IgM antibody that binds to about 50% of the melanomas, and 80% of the kidney carcinomas tested. The antigen defined by this antibody in melanomas has an apparent molecular weight of 155 kilodaltons and is denoted p155. It has not been observed on any normal adult or fetal tissues. The antigen present in the kidney carcinomas was not p155, but rather consisted of two proteins of approximately 60,000 and 250,000-300,000 daltons. This observation suggests the possibility that the antigenic determinant recognized by antibody 6.1 may be present on several distinct protein molecules.
用人类黑色素瘤细胞免疫BALB/c小鼠,然后将其脾细胞与NS-1骨髓瘤细胞杂交。筛选杂交细胞,以检测其产生与黑色素瘤细胞结合的抗体的能力。鉴定并克隆了两种具有有趣特异性的杂交瘤。杂交瘤5.1产生一种IgG1抗体,该抗体能与大约一半的测试黑色素瘤和癌结合。在十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)上,其靶标是一种表观分子量为210千道尔顿的多肽。这种抗原,记为p210,在正常成体脑和某些胎儿组织中也有表达。杂交瘤6.1产生一种IgM抗体,该抗体能与大约50%的黑色素瘤以及80%的测试肾癌结合。这种抗体在黑色素瘤中所定义的抗原表观分子量为155千道尔顿,记为p155。在任何正常成体或胎儿组织中均未观察到该抗原。肾癌中存在的抗原不是p155,而是由两种蛋白质组成,分子量约为60,000道尔顿和250,000 - 300,000道尔顿。这一观察结果提示,抗体6.1所识别的抗原决定簇可能存在于几种不同的蛋白质分子上。